A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Clinical trial NCT04497844 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04497844
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2025-01-07
- Enrollment
- 696
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.